Can we decode the hidden subtypes of early Parkinson's?

NCT ID NCT07752355

First seen Aug 07, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study investigates the biological mechanisms behind young-onset Parkinson's disease, which begins before age 50. Researchers will analyze genetic tests and protein markers in spinal fluid and skin biopsies from 250 participants to identify distinct disease subtypes. The goal is to better understand why the disease develops earlier in some people and to find biomarkers that could help tailor future treatments and clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could identify biological markers and genetic factors that help classify young-onset Parkinson's into subtypes, potentially guiding more personalized treatments and clinical trial design.
What could go wrong
This is an observational study, so it won't directly test a treatment. Findings may not lead to immediate clinical changes, and the biological markers studied may not prove to be reliable indicators across all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATE ONSET PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.